Cargando…

Fr582 A LOWER RISK FOR VITAMIN B12 DEFICIENCY DISTINGUISHES SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) CAUSED BY METHANE-PRODUCING ARCHAEA FROM SIBO CAUSED BY HYDROGEN-PRODUCING BACTERIA

Detalles Bibliográficos
Autores principales:	Madigan, Katelyn E., Weinberg, Richard B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2021
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108229/ http://dx.doi.org/10.1016/S0016-5085(21)01603-6

Ejemplares similares

Small intestinal bacterial overgrowth (SIBO) as a potential cause of impaired spermatogenesis
por: Tremellen, Kelton, et al.
Publicado: (2020)

Role of Small Intestinal Bacterial Overgrowth (SIBO) and Inflammation in Obese Children
por: Esposito, Susanna, et al.
Publicado: (2020)

Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)?
por: Rao, Satish S. C., et al.
Publicado: (2018)

The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO)
por: Polkowska-Pruszyńska, Beata, et al.
Publicado: (2020)

Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO) - A pilot study
por: Khalighi, A.R., et al.
Publicado: (2014)

Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection
por: Savva, K.-V., et al.
Publicado: (2021)

Brain Fogginess and SIBO: A Link or Just a Mirage?
por: Sachdeva, Sanjeev, et al.
Publicado: (2018)

Influence of Body Composition and Specific Anthropometric Parameters on SIBO Type
por: Wielgosz-Grochowska, Justyna Paulina, et al.
Publicado: (2023)

Chinese herbal medicine for the treatment of small intestinal bacterial overgrowth (SIBO): A protocol for systematic review and meta-analysis
por: Ren, Xuetong, et al.
Publicado: (2020)

A Promising Approach: Artificial Intelligence Applied to Small Intestinal Bacterial Overgrowth (SIBO) Diagnosis Using Cluster Analysis
por: Hao, Rong, et al.
Publicado: (2021)

Response to Sachdeva et al: Brain Fogginess and SIBO Is Not a Mirage
por: Rao, Satish S. C., et al.
Publicado: (2018)

Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO
por: Banaszak, Michalina, et al.
Publicado: (2023)

Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis
por: Rao, Satish S. C., et al.
Publicado: (2018)

Levothyroxine Sodium Oral Solution Normalizes Thyroid Function in a Patient with Hashimoto’s Disease, Gastritis, Diabetic Gastroparesis, and Small Intestinal Bacterial Overgrowth (SIBO)
por: Bohinc Henderson, Brittany
Publicado: (2021)

Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
por: Aslan, Ismail, et al.
Publicado: (2023)

Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)
por: Guo, Huaizhu, et al.
Publicado: (2023)

Effects of Bovine Colostrum with or without Egg on In Vitro Bacterial-Induced Intestinal Damage with Relevance for SIBO and Infectious Diarrhea
por: Playford, Raymond J., et al.
Publicado: (2021)

Fr195 PERCEPTIONS OF COVID-19 IN THE EOSINOPHILIC ESOPHAGITIS POPULATION
por: Thanawala, Shivani U., et al.
Publicado: (2021)

Fr090 IMPACT OF THE COVID-19 PANDEMIC ON ENDOSCOPY CANCELLATIONS
por: Wang, Connie W., et al.
Publicado: (2021)

Fr098 IMPACT OF COVID-19 PANDEMIC IN IBD PATIENT CARE
por: Dahiya, Monica, et al.
Publicado: (2021)

Fr002 EFFECT OF THE COVID-19 PANDEMIC ON ACUTE GASTROINTESTINAL BLEEDING
por: Reddy, Sumana, et al.
Publicado: (2021)

Show Me What You Have Inside—The Complex Interplay between SIBO and Multiple Medical Conditions—A Systematic Review
por: Sroka, Natalia, et al.
Publicado: (2022)

Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS
por: Livanos, Alexandra E., et al.
Publicado: (2021)

Fr094 UTILITY OF COVID-19 ANTIBODY TESTING FOR PRE-ENDOSCOPY SCREENING
por: Noorali, Anika, et al.
Publicado: (2021)

Fr096 PERCEPTIONS OF TELEMEDICINE OFFICE VISITS DURING THE COVID-19 PANDEMIC
por: Foliente, Ethan, et al.
Publicado: (2021)

Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Weissman, Simcha, et al.
Publicado: (2021)

Fr580 THE MICROBIOME AND SARS-COV-2: DAVID VERSUS A TINY GOLIATH
por: Hazan, Sabine, et al.
Publicado: (2021)

Fr230 EFFECT ON EARLY GROWTH OF OFFSPRING BY UNDIAGNOSED MATERNAL CELIAC DISEASE IN PREGNANCY
por: Choung, Rok Seon, et al.
Publicado: (2021)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Fr006 IMPACT OF A SARS-COV2 INFECTION IN PATIENTS WITH CELIAC DISEASE
por: Elli, Luca, et al.
Publicado: (2021)

Fr137 FIRST HIGH DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19
por: Jha, Divya, et al.
Publicado: (2021)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Fr500 COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Fr502 INFLAMMATORY BOWEL DISEASE AND COVID-19: A LARGE INTEGRATED HEALTHCARE EXPERIENCE
por: Tashjian, Vartan C., et al.
Publicado: (2021)

Fr005 SEVERE COVID-19 ASSOCIATED WITH INCREASED RISK OF GI BLEEDING DURING HOSPITALIZATION
por: Alvencar, Sujay, et al.
Publicado: (2021)

Fr099 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC.
por: Olayinka, Lily, et al.
Publicado: (2021)

Fr100 TELEMEDICINE IN GASTROENTEROLOGY: A STUDY ON FEASIBILITY AND PATIENTS’ TRUST DURING COVID-19 PANDEMIC.
por: Costantino, Andrea, et al.
Publicado: (2021)

Fr015 FACTORS RELATED TO NEW ONSET DYSPEPSIA AFTER COVID 19 INFECTION IN MEXICAN POPULATION
por: Rendon, Ricardo Flores, et al.
Publicado: (2021)

Fr012 THE OBSERVED RISK OF RECURRENT BLEEDING AND THROMBOEMBOLIC DISEASE IN COVID-19 PATIENTS WITH GASTROINTESTINAL BLEEDING.
por: Attah, Emmanuel O., et al.
Publicado: (2021)

Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE
por: Ricciuto, Amanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2s7q7ms5itqn055mtsj8efmb2t